Adenylyl Cyclase‑associated Protein�1‑targeted Nanoparticles as a Novel Strategy for the Treatment of Metastatic Non‑small Cell Lung Cancer

International Journal of Oncology - Greece
doi 10.3892/ijo.2019.4822
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Targeted Therapy for the Treatment of Advanced Non-Small Cell Lung Cancer

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2005English

Unmet Needs in the Treatment of Metastatic Non-Small-Cell Lung Cancer

European Oncology and Haematology
OncologyHematology
2008English

A Systematic Review of the Cost-Effectiveness of Targeted Therapies for Metastatic Non-Small Cell Lung Cancer (NSCLC)

BMC Pulmonary Medicine
PulmonaryRespiratory Medicine
2014English

A Decade of Targeted Therapy for Non-Small Cell Lung Cancer

2017English

Profile of Ramucirumab in the Treatment of Metastatic Non-Small-Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2016English

Zein Nanoparticles as Nontoxic Delivery System for Maytansine in the Treatment of Non-Small Cell Lung Cancer

Drug Delivery
MedicinePharmaceutical Science
2019English

Targeting FBW7 as a Strategy to Overcome Resistance to Targeted Therapy in Non–Small Cell Lung Cancer

Cancer Research
Cancer ResearchOncology
2017English

Immunotherapy for the First-Line Treatment of Patients With Metastatic Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2019English

Nivolumab in Metastatic Non–Small Cell Lung Cancer

Journal of the Advanced Practitioner in Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy